Answer
Ximaract (cefuroxime sodium) can be used during breastfeeding; cefuroxime is expected to enter human milk in very small quantities, and adverse effects at therapeutic doses are not expected.
Sources for this answer
- XimaractBausch & Lomb U.K Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked